📰 Mark Enyedy News
Page 2 - Mark Enyedy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Enyedy. Real-time updates on events, politics, business and more.
November 30, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
November 3, 2023
Operator: Good morning, ladies and gentlemen, and welcome to ImmunoGens Third Quarter 2023 Financial and Operating Results Conference Call. Todays conference is being recorded.
November 2, 2023
ELAHERE's Strong Demand Drives Revenue Growth
September 18, 2023
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Lauren White has been appointed Senior Vice President and Chief...
August 28, 2023
ImmunoGen, Inc. (NASDAQ: IMGN) inked pacts with Takeda Pharmaceutical Company Limited (NYSE: TAK) to develop and 
August 2, 2023
Operator: Good morning and welcome to ImmunoGen’s second quarter 2023 financial and operating results conference call. Today’s conference is being recorded.
July 31, 2023
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Anna Berkenblit, MD, Senior Vice President and Chief Medical Officer,...
May 24, 2023
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Mark Enyedy, President and CEO, and Anna Berkenblit, Chief Medical... | June 11, 2023
May 24, 2023
FinancialContent fully hosted finance channel
May 3, 2023
ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer   Results Show Statistically Significant Improvements in PFS, ORR, and OS Compared to Chemotherapy First Medicine to Demonstrate an Overall Survival Adv...